A previously unrecognized role of C3a in proteinuric progressive nephropathy

Marina Morigi1, Monica Locatelli1, Cinzia Rota1

  • 1IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.

Scientific Reports
|June 28, 2016
PubMed

Insights

Uncontrolled complement alternative pathway (AP) activation drives podocyte loss and parietal epithelial cell (PEC) activation, leading to glomerulosclerosis in proteinuric kidney diseases.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Podocyte loss initiates glomerulosclerosis, a key feature of proteinuric nephropathies.
  • Understanding glomerular injury mechanisms is crucial for developing new therapeutic targets.

Purpose of the Study:

  • To investigate if the complement alternative pathway (AP) mediates podocyte depletion and parietal epithelial cell (PEC) activation in protein-overload-induced glomerulosclerosis.
  • To explore the role of C3a, CXCR4, and GDNF/c-Ret signaling in this process.

Main Methods:

  • Utilized mice deficient in Factor H or Factor B, alongside wild-type littermates, subjected to bovine serum albumin (BSA)-induced protein overload.
  • Conducted in vitro studies using PECs and analyzed patient samples from proteinuric nephropathy cases.

Main Results:

  • BSA-induced protein overload caused podocyte depletion, PEC activation, and glomerulosclerosis in wild-type mice, exacerbated in Factor H-deficient mice.
  • Factor B deficiency protected against glomerular injury, confirming the pathogenic role of the AP.
  • Complement component C3a directly promoted PEC proliferation and migration, an effect amplified by podocyte-derived GDNF via the c-Ret axis.
  • Glomerular C3/C3a, PEC activation, CXCR4, and GDNF were upregulated in both mouse models and human proteinuric nephropathy patients.

Conclusions:

  • Uncontrolled activation of the complement alternative pathway is essential for podocyte-dependent PEC activation and subsequent glomerulosclerosis.
  • Targeting the AP, C3a, or the GDNF/c-Ret/CXCR4 axis may offer novel therapeutic strategies for proteinuric kidney diseases.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
586
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
300
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
421
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.7K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1000
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
848